Ontology highlight
ABSTRACT: Importance
Suboptimal adherence to endocrine therapy (ET) among patients with hormone-receptor-positive breast cancer significantly affects survival outcomes and is associated with higher hospitalization rates and health care costs. Weak adherence to long-term treatments has multiple determinants, including disease characteristics, treatment adverse effects, and patients' attributes, such as age and comorbidities.Objective
To examine whether potential drug-drug interactions (PDDI) with tamoxifen or aromatase inhibitor were associated with adherence to ET in patients with early and advanced breast cancer.Design, setting, and participants
This cohort study used anonymized health record data of women with breast cancer who received ET in a private observational primary
SUBMITTER: Rassy E
PROVIDER: S-EPMC9719053 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature